おすすめの製品
由来生物
mouse
品質水準
結合体
unconjugated
抗体製品の状態
purified antibody
抗体製品タイプ
primary antibodies
クローン
6C2-G9, monoclonal
分子量
calculated mol wt 141.18 kDa
observed mol wt ~200 kDa
化学種の反応性
virus
包装
antibody small pack of 100 μg
テクニック
ELISA: suitable
immunoprecipitation (IP): suitable
neutralization: suitable
western blot: suitable
アイソタイプ
IgG1
UniProtアクセッション番号
輸送温度
dry ice
保管温度
-10 to -25°C
ターゲットの翻訳後修飾
unmodified
詳細
Spike glycoprotein (UniProt: P0DTC2; also known as S glycoprotein, E2, Peplomer protein) is encoded by the S (also known as 2) gene (Gene ID: 43740568) in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 is a positive-strand RNA virus that causes severe respiratory syndrome in human. The mature SARS-CoV-2 contains 4 structural proteins: Envelope (E), Membrane (M), Nucleocapsid (N), and the Spike protein (S). E and M proteins help in viral assembly and N protein is needed for RNA synthesis. The S protein is a single-pass type I, homotrimeric, membrane glycoprotein that is responsible for virus binding and entry into host cell. It is synthesized with a signal peptide (aa 1-12), which is subsequently cleaved off to generate the mature protein that contains an extracellular domain (aa 13-1213), a transmembrane domain (aa 1214-1234), and a cytoplasmic domain 1235-1273). The S protein is further processed into S1 (aa 13-685) and S2 (aa 686-1273) subunits by host cell furin. The presence of a furin polybasic cleavage site in S protein from SARS-CoV-2 sets it apart from S protein in SARS-CoV that possesses a monobasic S1/S2 cleavage site. The S1 subunit has the receptor binding domain (RBD; aa 319-541) that mediates entry of SARS-CoV-2 into sensitive cells through the peptidase domain of host Angiotensin-converting enzyme 2 (ACE2) with high affinity (KD = 15 nM). The S2 protein, which is reported to be well conserved, is responsible for membrane fusion. Clone 6C2-G9 binds to RBD of the SARS-CoV-2 spike protein.
特異性
Clone 6C2-G9 is a mouse monoclonal antibody that detects the receptor binding domain (RBD) in the spike protein of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
免疫原
His-tagged recombinant fragment corresponding to the receptor binding domain (319-541) within the spike protein of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
アプリケーション
Quality Control Testing
Evaluated by Western Blotting in lysate from HEK293T cells expressing full-length spike protein of SARS-CoV-2 virus.
Western Blotting Analysis (WB): A 1:1,000 dilution of this antibody detected Spike glycoprotein in HEK293T cells expressing full-length spike protein of SARS-CoV-2, but not in lysate from wild-type HEK293T cells.
Tested Applications
Neutralizing: A representative lot neutralized SARS-CoV-2 Spike protein RBD to ACE2 in Neutralizing applications (Courtesy of Kento Abe and Anne-Claude Gingras, Toronto).
ELISA Analysis: A 1:3 dilution from a representative lot detected SARS-CoV-2 Spike protein. (Courtesy of Stefan Schüchner, Ingrid Mudrak, Ingrid Frohner, and Egon Ogris (Max Perutz Labs, Medical University of Vienna, Austria).
Western Blotting Analysis: A 1:400 dilution from a representative lot detected Sars-CoV-2 Spike protein in Whole cell lysates of HEK293T cells expressing full-length spike protein of SARS-CoV-2. (Courtesy of Stefan Schüchner, Ingrid Mudrak, Ingrid Frohner, and Egon Ogris (Max Perutz Labs, Medical University of Vienna, Austria).
Neutralizing: A representative lot neutralized SARS-CoV-2 Spike protein RBD binding to ACE2 receptor. (Abe, K.T., et al. (2020). JCI Insight 5(19):e142362).
Immunoprecipitation Analysis: A representative lot immunoprecipitated SARS-CoV-2 Spike protein. (Courtesy of Stefan Schüchner, Ingrid Mudrak, Ingrid Frohner, and Egon Ogris (Max Perutz Labs, Medical University of Vienna, Austria).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Evaluated by Western Blotting in lysate from HEK293T cells expressing full-length spike protein of SARS-CoV-2 virus.
Western Blotting Analysis (WB): A 1:1,000 dilution of this antibody detected Spike glycoprotein in HEK293T cells expressing full-length spike protein of SARS-CoV-2, but not in lysate from wild-type HEK293T cells.
Tested Applications
Neutralizing: A representative lot neutralized SARS-CoV-2 Spike protein RBD to ACE2 in Neutralizing applications (Courtesy of Kento Abe and Anne-Claude Gingras, Toronto).
ELISA Analysis: A 1:3 dilution from a representative lot detected SARS-CoV-2 Spike protein. (Courtesy of Stefan Schüchner, Ingrid Mudrak, Ingrid Frohner, and Egon Ogris (Max Perutz Labs, Medical University of Vienna, Austria).
Western Blotting Analysis: A 1:400 dilution from a representative lot detected Sars-CoV-2 Spike protein in Whole cell lysates of HEK293T cells expressing full-length spike protein of SARS-CoV-2. (Courtesy of Stefan Schüchner, Ingrid Mudrak, Ingrid Frohner, and Egon Ogris (Max Perutz Labs, Medical University of Vienna, Austria).
Neutralizing: A representative lot neutralized SARS-CoV-2 Spike protein RBD binding to ACE2 receptor. (Abe, K.T., et al. (2020). JCI Insight 5(19):e142362).
Immunoprecipitation Analysis: A representative lot immunoprecipitated SARS-CoV-2 Spike protein. (Courtesy of Stefan Schüchner, Ingrid Mudrak, Ingrid Frohner, and Egon Ogris (Max Perutz Labs, Medical University of Vienna, Austria).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Anti-SARS-CoV-2 Spike RBD, clone 6C2-G9, Cat. No. MABF2815, is a mouse monoclonal antibody that detects Spike glycoprotein of SARS-CoV-2 and is tested for use in ELISA, Immunoprecipitation, Neutralizing, and Western Blotting.
物理的形状
Purified mouse monoclonal antibody IgG1 in PBS without azide.
保管および安定性
Store at -10°C to -25°C. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
その他情報
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
免責事項
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
適切な製品が見つかりませんか。
製品選択ツール.をお試しください
保管分類コード
12 - Non Combustible Liquids
WGK
WGK 2
引火点(°F)
Not applicable
引火点(℃)
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
MABF2815-25UG:
MABF2815-100UG:
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)